Sensible and Sensitive AI for Worker Wellbeing: Factors that Inform Adoption and Resistance for Information WorkersVedant Das Swain, Northeastern University; et al.Lan Gao, University of Chicago
2026年4月9日18:58 文化版块
，更多细节参见快连VPN
Premium & FT Weekend Print
The market for weight-loss medications is still expanding, too. Drugmaker Novo Nordisk NVO announced Tuesday that a higher dosage of its Wegovy injectable is now available in the U.S., adding another option to the marketplace just a week after the Food and Drug Administration approved Foundayo, a weight-loss pill developed by competitor Eli Lilly LLY.